Event Brief
Jan 5, 2026 at 12:03 AM ET
Insilico Signs $888M AI Drug Deal After IPO
By The BriefBrief
Insilico Medicine partners with Servier for AI-driven cancer drug development, following a successful IPO.
WHO: Insilico Medicine, Servier
WHAT: AI drug-development partnership
WHEN: Jan 4, 2026 at 7:00 PM ET
WHERE: Hong Kong
WHY: To discover and develop novel cancer drugs
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21434 of 21434
Same format. Every time.
Continue reading — sign in or create a free account with
